// App-Quantinova.ai

6567 : Real-world EQ5D health utility values for metastatic lung cancer patients by molecular alteration and response to therapy.

Researchers

Presenter

  • Catherine Labbe

Principal Investigators

  • Catherine Brown

  • Andrea Perez Cosio

  • Ashlee Vennettilli

  • Devalben Patel

  • Nicholas Y. Cheng

  • Mindy Liang

  • Gursharan Gill

  • Alexandra Rett

  • Yvonne Leung

  • Hiten Naik

  • Lawson Eng

  • Nicole Mittmann

  • Natasha B. Leighl

  • Ronald Feld

  • Penelope Ann Bradbury

  • Frances A. Shepherd

  • Doris Howell

  • Geoffrey Liu

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

  • Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada

  • Universtiy Health Network, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University Health Network, Ontario Cancer Institute, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved